Literature DB >> 12183278

Comparative evaluation of disk diffusion with microdilution assay in susceptibility testing of caspofungin against Aspergillus and Fusarium isolates.

Sevtap Arikan1, Victor Paetznick, John H Rex.   

Abstract

We compared the disk diffusion and broth microdilution methods for susceptibility testing of caspofungin against Aspergillus (n = 78) and Fusarium (n = 22) isolates. Microdilution testing followed the NCCLS M-38P guidelines but was performed in antibiotic medium 3 supplemented to 2% glucose (AM3). Disk diffusion assays were performed on AM3 agar plates with a 2- micro g caspofungin disk. By both methods, caspofungin showed favorable activity against Aspergillus isolates and no activity against Fusarium isolates. In the disk-based format, intrazonal growth that was not influenced by the drug concentration gradient was consistently observed for all of the Aspergillus isolates tested.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183278      PMCID: PMC127447          DOI: 10.1128/AAC.46.9.3084-3087.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

Review 1.  Hitting a new target with echinocandins. Why chase something else?

Authors:  J R Graybill
Journal:  Curr Opin Investig Drugs       Date:  2001-04

2.  Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model.

Authors:  G M González; R Tijerina; L K Najvar; R Bocanegra; M Luther; M G Rinaldi; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds.

Authors:  M Del Poeta; W A Schell; J R Perfect
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

4.  Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors.

Authors:  J Onishi; M Meinz; J Thompson; J Curotto; S Dreikorn; M Rosenbach; C Douglas; G Abruzzo; A Flattery; L Kong; A Cabello; F Vicente; F Pelaez; M T Diez; I Martin; G Bills; R Giacobbe; A Dombrowski; R Schwartz; S Morris; G Harris; A Tsipouras; K Wilson; M B Kurtz
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

5.  In vitro activity of a new pneumocandin antifungal, L-743,872, against azole-susceptible and -resistant Candida species.

Authors:  J A Vazquez; M Lynch; D Boikov; J D Sobel
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

Review 6.  Lipopeptide inhibitors of fungal glucan synthase.

Authors:  M B Kurtz; C M Douglas
Journal:  J Med Vet Mycol       Date:  1997 Mar-Apr

7.  Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B.

Authors:  M Cuenca-Estrella; E Mellado; T M Díaz-Guerra; A Monzón; J L Rodríguez-Tudela
Journal:  J Antimicrob Chemother       Date:  2000-09       Impact factor: 5.790

8.  In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates.

Authors:  S Arikan; M Lozano-Chiu; V Paetznick; J H Rex
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

Review 9.  Update on antifungals targeted to the cell wall: focus on beta-1,3-glucan synthase inhibitors.

Authors:  N H Georgopapadakou
Journal:  Expert Opin Investig Drugs       Date:  2001-02       Impact factor: 6.206

10.  In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373.

Authors:  K Bartizal; T Scott; G K Abruzzo; C J Gill; C Pacholok; L Lynch; H Kropp
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

View more
  13 in total

1.  Effect of culture medium on the disk diffusion method for determining antifungal susceptibilities of dermatophytes.

Authors:  Belkys Fernández-Torres; Alfonso Carrillo-Muñoz; Isabel Inza; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

2.  Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.

Authors:  A Espinel-Ingroff; B Arthington-Skaggs; N Iqbal; D Ellis; M A Pfaller; S Messer; M Rinaldi; A Fothergill; D L Gibbs; A Wang
Journal:  J Clin Microbiol       Date:  2007-04-11       Impact factor: 5.948

3.  Evaluation of the disk diffusion method compared to the microdilution method in susceptibility testing of anidulafungin against filamentous fungi.

Authors:  Carmelo Massimo Maida; Maria Eleonora Milici; Laura Trovato; Salvatore Oliveri; Emanuele Amodio; Elisabetta Spreghini; Giorgio Scalise; Francesco Barchiesi
Journal:  J Clin Microbiol       Date:  2008-10-15       Impact factor: 5.948

4.  Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.

Authors:  Michael A Thiel; Annelies S Zinkernagel; Jürgen Burhenne; Claude Kaufmann; Walter E Haefeli
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

5.  Comparative Evaluation of Disc Diffusion and E-test with Broth Micro-dilution in Susceptibility testing of Amphotericin B, Voriconazole and Caspofungin against Clinical Aspergillus isolates.

Authors:  Prashant Gupta; Vineeta Khare; Deepak Kumar; Abrar Ahmad; Gopa Banerjee; Mastan Singh
Journal:  J Clin Diagn Res       Date:  2015-01-01

Review 6.  Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis.

Authors:  Gillian Keating; David Figgitt
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  New methods to assess susceptibilities of Aspergillus isolates to caspofungin.

Authors:  Alexander Imhof; S Arunmozhi Balajee; Kieren A Marr
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

8.  Disk diffusion-based methods for determining Candida parapsilosis susceptibility to anidulafungin.

Authors:  Zekaver Odabasi; Victor Paetznick; Beth P Goldstein; John H Rex; Luis Ostrosky-Zeichner
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

9.  Comparison of two methods and three end points in determination of in vitro activity of micafungin against Aspergillus spp.

Authors:  Sevtap Arikan; Pinar Yurdakul; Gulsen Hascelik
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

10.  Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.

Authors:  D J Diekema; S A Messer; R J Hollis; R N Jones; M A Pfaller
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.